What 国家卫生健康委卫生发展研究中心 does

国家卫生健康委卫生发展研究中心 (China National Health Development Research Center, CNHDRC) is a national-level government public institution (事业单位) directly subordinate to the National Health Commission of the People's Republic of China, established in the early 1990s. It functions as a policy think tank and technical standards body covering eight research domains: health economics and costs, health security, pharmaceutical pricing, health strategy and global health, healthcare service systems, health workforce, drug evaluation and policy, and health technology assessment. Its primary customers are the National Health Commission and provincial/municipal health authorities, to whom it delivers policy research, technical advisory, and standards development.

The center's core outputs are authoritative national guidelines and technical standards rather than commercial products. Notable deliverables include cardiovascular, anti-tumor, and pediatric drug clinical comprehensive evaluation technical guidelines (2022 versions); Drug Clinical Comprehensive Evaluation Quality Control Guidelines (2024 version); and service guidelines for medical imaging centers and ECG diagnostic centers in compact county medical communities (2025). It also houses the National Drug and Health Technology Comprehensive Evaluation Center (国家药物和卫生技术综合评估中心) as a wholly-owned subsidiary. The center operates as the WHO Collaborating Centre for Health Systems Strengthening and serves as the domestic technical mirror body for ISO/TC304 (Healthcare Organization Management), with active working groups on smart hospitals, pandemic response, and medical textiles. Its technology stack centers on health technology assessment systems, health economics and financing analysis, medical pricing standards development, and integrated healthcare service delivery research.

The business model is non-commercial: the center is funded entirely through government budget allocations and operates within the policy framework of the National Health Commission. It disseminates work through academic conferences, peer-reviewed publications, signed articles in mainstream media (People's Daily, Economic Daily, Guangming Daily, National Governance), and direct advisory channels to government decision-makers. International engagement has expanded materially, with delegations to WHO headquarters in Geneva (May 2026), China-Germany healthcare think tank dialogues, and ongoing China-WHO collaborative projects covering 8 provinces and 9 pilot cities. The organization has no equity funding, no public listing, and no commercial pricing structure.

Name

国家卫生健康委卫生发展研究中心

Legal name

国家卫生健康委卫生发展研究中心

Website

https://cnhdrc.cn

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

The China National Health Development Research Center is a government public institution under China's National Health Commission that delivers health policy research, technical standards, and advisory services on health economics, drug evaluation, and healthcare system reform to national and provincial health authorities.

Ownership category

akta.pro rank

Product category

Health Policy Research

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Monitoring, Evaluation, Performance Management & Quality Improvement (HLAJAMAJ)

akta.pro secondary industries

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN), Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN), Health Research Funding Agencies (Public/Quasi-Public) (HLAJALAB)

Keywords

• Health policy research
• Health technology assessment
• Health economics analysis
• Drug evaluation guidelines
• Healthcare system reform

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Others

Revenue model

1. Government Funding: As a direct subordinate public institution of the National Health Commission, the center receives government budget allocations for research activities, policy advisory services, and international cooperation projects.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

The China National Health Development Research Center is a national-level public research institution under the National Health Commission that conducts health policy research, health economics analysis, and health technology assessment for China's healthcare reform. It produces authoritative national guidelines and technical standards, including clinical drug evaluation guidelines for cardiovascular, anti-tumor, and pediatric drugs, integrated healthcare service system standards, and serves as the WHO Collaborating Centre for Health Systems Strengthening and the domestic mirror body for ISO/TC304 international healthcare standards.

Product overview

国家卫生健康委卫生发展研究中心 is a national-level research institution under the National Health Commission, serving as a think tank for health policy research. It operates various research divisions covering health economics, health security, pharmaceutical pricing, health strategy, health service systems, health workforce, drug evaluation, and health technology assessment. The institution also houses the 国家药物和卫生技术综合评估中心 (National Center for Drug and Health Technology Assessment) which develops clinical evaluation guidelines for drugs, medical technologies, and specialized disease areas. The center produces authoritative guidelines and technical standards for China's healthcare system, including guidelines for integrated county-level medical communities (县域医共体), medical imaging centers, ECG diagnostic centers, and drug clinical evaluation. As China's technical counterpart to ISO/TC304 (Healthcare Organization Management), it also contributes to international standardization efforts in smart hospitals and pandemic response.

Differentiator

Problem solved

Functional benefit

Products and services

• National Drug and Health Technology Comprehensive Evaluation Center (国家药物和卫生技术综合评估中心)
• National Drug Clinical Comprehensive Evaluation Technical Guidelines — Cardiovascular Drugs (2022 Version)
• National Drug Clinical Comprehensive Evaluation Technical Guidelines — Anti-tumor Drugs (2022 Version)
• National Drug Clinical Comprehensive Evaluation Technical Guidelines — Pediatric Drugs (2022 Version)
• Drug Clinical Comprehensive Evaluation Quality Control Guidelines (2024 Version)

Quantifiable outcome

• Developed and issued national guidelines for compact county medical community medical imaging and ECG diagnostic centers, covering over 90% of county regions nationwide.
• +3 more outcomes

Named customers2 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• German-Chinese Medical Society (DCGM) / IGES InstitutecoreStrategic or Co-development Partner · 1 May 2026The center organized a China-Germany healthcare think tank dialogue series in Germany in May 2026, collaborating with the German-Chinese Medical Society and the German IGES Institute. Discussions focused on healthcare reform experiences, integrated healthcare service system construction, and think tank operations. Both parties reached cooperation intentions.
• Gesundes Kinzigtal (Germany)minorStrategic or Co-development Partner · 1 May 2026The center visited and investigated the German Gesundes Kinzigtal integrated healthcare system in May 2026 to learn about its integrated healthcare construction理念 and practical experience.
• China-WHO Cooperation Project on Quality Integrated Healthcare Service SystemcoreStrategic or Co-development Partner · 1 December 2024Joint project with WHO under the China-WHO Biennial Cooperation Framework. The center serves as one of four national technical support institutions providing guidance to 8 provinces and 9 pilot cities. The center specifically guides Qingdao, Handan, and Tongliao cities, and also leads the information technology专题 technical guidance.
• World Health Organization (WHO)coreStrategic or Co-development Partner · 1 January 2024The center serves as the WHO Collaborating Centre for Health Systems Strengthening and the WHO Classification Terminology and Standards Cooperation Centre. It actively participates in WHO World Health Assemblies, hosts joint seminars, and provides technical guidance on digital health and universal health coverage. Center Director Zhu Hongming visited WHO headquarters in May 2026 for深化数智健康与全民健康覆盖合作的 discussions.
• Peking University China Center for Health Development ResearchcoreStrategic or Co-development PartnerPartner institution in the China-WHO Quality Integrated Healthcare Service System project, providing technical support as one of four national expert institutions.
• Tsinghua University Vanke School of Public HealthcoreStrategic or Co-development PartnerPartner institution in the China-WHO Quality Integrated Healthcare Service System project, providing technical support as one of four national expert institutions.
• Hainan Health Development Research InstitutecoreStrategic or Co-development PartnerPartner institution in the China-WHO Quality Integrated Healthcare Service System project, providing technical support as one of four national expert institutions.
• National Health Commission Reform Office / International DepartmentcoreStrategic or Co-development PartnerThe center participates in projects under the guidance of the NHC Reform Department and International Department, with the project management office located at the NHC Project Fund Supervision Service Center.
• Chinese Health Economics AssociationminorStrategic or Co-development PartnerRelated research institution listed on the center's website for collaboration in health economics research and academic exchange.
• ISO/TC304 (International Organization for Standardization — Healthcare Organization Management Technical Committee)coreStrategic or Co-development PartnerThe center serves as the domestic technical mirror body for ISO/TC304, responsible for collecting and submitting international standard proposals in healthcare organization management. Working groups cover vocabulary, pandemic response, medical textiles, and smart hospitals.
• International Association for Ambulatory Surgery (IAAS)minorStrategic or Co-development PartnerThe center's experts participate in IAAS conferences. Vice President Yu Lihua was elected Executive Committee member, and Zhang Zhenzhong served as Executive Committee理事 for five consecutive terms. The center shares China's day surgery experience at international forums.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Shanghai Health Development Research Center: The Shanghai municipal health development research center is explicitly linked on the subject center's website as a peer local-level health development research institution and a comparable sub-national government health policy research body.

Broad incumbents

• Development Research Center of the State Council: The State Council's Development Research Center is a higher-level government policy think tank linked on the subject center's website; it conducts cross-sectoral policy research including health policy and is comparable as a Chinese government-affiliated research and advisory institution.
• National Institutes of Health (NIH): NIH is the U.S. federal government's primary biomedical and public health research agency and the most globally prominent analog to a national health research and advisory institution under government authority.
• Santé Publique France: Santé Publique France is France's national public health agency, conducting population health research, surveillance, and policy advisory for the government — comparable in function and structure to the subject center as a national government public health research institution.
• Robert Koch Institute (RKI): RKI is Germany's federal government agency for disease control and prevention, providing public health research, surveillance, and policy advisory — a comparable national government public health research function with which the subject center maintains a dialogue relationship.
• Chinese Academy of Medical Sciences (CAMS) / Peking Union Medical College: CAMS/PUMC is the national academic medical research institution that conducts broader biomedical, clinical, and public health research and provides scientific advisory to the NHC, overlapping with the subject center's health research and policy mandate.

Direct peers

• Chinese Center for Disease Control and Prevention (China CDC): China CDC is a national public health agency under the NHC that conducts public health research, surveillance, and policy advisory. It is directly comparable as a national-level public health research and advisory institution within the same parent ministry system.
• Peking University China Center for Health Development Research: Peking University's health policy research center is a formal partner institution on the China-WHO integrated healthcare pilot and competes with the subject center as a leading national health economics and policy research organization in China.
• Tsinghua University Vanke School of Public Health: Tsinghua's Vanke School of Public Health is also a partner on the China-WHO integrated healthcare pilot and operates as a competing national-level health policy and health economics research hub closely tied to the NHC policy ecosystem.

Emerging players

• National Institute for Health and Care Excellence (NICE, UK): NICE provides health technology assessment and clinical guideline development for the UK NHS — directly comparable to the subject center's drug and health technology evaluation function, even though it is structurally an arms-length body rather than a direct ministerial institution.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/%E5%9B%BD%E5%AE%B6%E5%8D%AB%E7%94%9F%E5%81%A5%E5%BA%B7%E5%A7%94%E5%8D%AB%E7%94%9F%E5%8F%91%E5%B1%95%E7%A0%94%E7%A9%B6%E4%B8%AD%E5%BF%83

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 国家卫生健康委卫生发展研究中心